Author

Charlotte Romanet

Institut universitaire de cardiologie et de pneumologie de QuébecORCID 0000-0003-3583-2758Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Pathology· 1 Physiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:cell signaling & trafficking· 2 Approach:experimental assay· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:metabolism & bioenergetics· 1

Frequent Co-Authors

Alice Bourgeois· 2 shared Andréanne Pelletier· 2 shared Charlie Théberge· 2 shared François PotusiD· 2 shared Manon MouginiD· 2 shared Mélanie Sauvaget· 2 shared Olivier BoucheratiD· 2 shared Reem El Kabbout· 2 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPathology

Alice Bourgeois

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

PathologyCirculationPeer-reviewedJan 20, 2025

Exploring Integrin α5β1 as a Potential Therapeutic Target for Pulmonary Arterial Hypertension: Insights from Comprehensive Multicenter Preclinical Studies

Sarah-Eve S Lemay, Mónica S. Montesinos, Yann Grobs…·Sébastien Bonnet

The study identifies integrin α5β1 as a key driver of pulmonary vascular remodeling in PAH and shows its inhibition improves hemodynamics and RV function in preclinical models.

31 citationstop 1%

humanbulk RNA-seq

𝕏 PostBluesky

PhysiologyScience Translational MedicinePeer-reviewedDec 11, 2024

ATP Citrate Lyase Drives Vascular Remodeling Diseases Development Through Metabolic-Epigenetic Reprograming.

Yann Grobs, Charlotte Romanet, Sarah-Eve S Lemay…·Sébastien Bonnet

This study identifies ATP-citrate lyase as a driver of vascular remodeling in pulmonary hypertension and coronary artery disease, showing its inhibition can reverse pathological changes.

43 citationstop 1%

humanbulk RNA-seq

𝕏 PostBluesky